Alendronate improves QOL of postmenopausal women with osteoporosis
Hisaya Kawate1, Keizo Ohnaka2, Masahiro Adachi1, Suminori Kono3, Hideyuki Ikematsu4, Hisashi Matsuo5, Kazumi Higuchi6, Takehiko Takayama7, Ryoichi Takayanagi11Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 2Department of Geri...
Saved in:
| Main Authors: | Hisaya Kawate, Keizo Ohnaka, Masahiro Adachi, et al |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2010
|
| Subjects: | |
| Online Access: | https://doaj.org/article/57f39a428a7b4d1bb5515ca81e8f1365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
by: Fan T, et al.
Published: (2013) -
Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation
by: Imai K
Published: (2013) -
Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
by: Kawate H, et al.
Published: (2011) -
Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage
by: Siris ES, et al.
Published: (2015)